G1, a GPER selective agonist, can inhibit the production of LPS-induced cytokines in the animal model of multiple sclerosis and Parkinson’s disease (Blasko et al., 2009; Mendes-Oliveira et al., 2017). This evidence concerns the gene GPER1 and multiple sclerosis.